Shares of Dr. Lal PathLabs Ltd traded largely unchanged on Thursday amid a volatile market, as investors awaited the company’s September quarter results and key board decisions.
Bonus Issue and Interim Dividend on the Agenda
The company’s board of directors is set to consider its first-ever bonus share issuance, marking a potential milestone for shareholders. In addition, the board will deliberate on declaring an interim dividend alongside the quarterly results.
While Dr. Lal PathLabs has never previously announced a bonus issue or stock split, it maintains a strong dividend record — distributing nearly ₹126 per share in dividends since 2016, including ₹24 per share since November 2024.
The record date for both the bonus issue and interim dividend will be announced later. The company has over 1.05 lakh retail shareholders (holding up to ₹2 lakh each), while promoter shareholding stands at 53.21%.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.